{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:40:52Z","timestamp":1792978852627,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371423"],"award-info":[{"award-number":["81371423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1712-3","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T08:33:26Z","timestamp":1543912406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The treatment value of IL-1\u03b2 monoclonal antibody under the targeting location of alpha-methyl-l-tryptophan and superparamagnetic iron oxide nanoparticles in an acute temporal lobe epilepsy model"],"prefix":"10.1186","volume":"16","author":[{"given":"Yanli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingrao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"issue":"4","key":"1712_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.33588\/rn.6104.2015181","volume":"61","author":"CA Espinosa-Jovel","year":"2015","unstructured":"Espinosa-Jovel CA, Sobrino-Mej\u00eda FE. Drug resistant epilepsy. Clinical and neurobiological concept. Revista De Neurologia. 2015;61(4):159.","journal-title":"Revista De Neurologia"},{"issue":"4","key":"1712_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475\u201382.","journal-title":"Epilepsia."},{"issue":"9971","key":"1712_CR3","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","volume":"385","author":"SL Moshe","year":"2015","unstructured":"Moshe SL, et al. Epilepsy: new advances. Lancet. 2015;385(9971):884\u201398.","journal-title":"Lancet."},{"issue":"5","key":"1712_CR4","first-page":"607","volume":"5","author":"A Vezzani","year":"2011","unstructured":"Vezzani A, Friedman A. Brain inflammation as a biomarker in epilepsy. Biomark. 2011;5(5):607\u201314.","journal-title":"Biomark."},{"key":"1712_CR5","first-page":"195","volume":"7","author":"D Xu","year":"2013","unstructured":"Xu D, et al. Immune mechanisms in epileptogenesis. Front Cell Neurosci. 2013;7:195.","journal-title":"Front Cell Neurosci."},{"issue":"2","key":"1712_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","volume":"8","author":"M Mattia","year":"2011","unstructured":"Mattia M, et al. Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutic. 2011;8(2):304\u201315.","journal-title":"Neurotherapeutic."},{"issue":"23\u201324","key":"1712_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.drudis.2008.09.005","volume":"13","author":"L Juillerrat-Jaannerert","year":"2008","unstructured":"Juillerrat-Jaannerert L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov Today. 2008;13(23\u201324):1099\u2013106.","journal-title":"Drug Discov Today."},{"issue":"14","key":"1712_CR8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.addr.2006.09.013","volume":"58","author":"C Corot","year":"2006","unstructured":"Corot C, et al. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006;58(14):1471\u2013504.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"1712_CR9","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1021\/la0636199","volume":"23","author":"JL Zhang","year":"2007","unstructured":"Zhang JL, et al. Core-shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: synthesis, characterization, and LCST of viable drug-targeting delivery system. Langmuir. 2007;23(11):6342\u201351.","journal-title":"Langmuir"},{"issue":"8","key":"1712_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1741-7015-8-83","volume":"13","author":"KK Jain","year":"2010","unstructured":"Jain KK. Advances in the field of nanoonclology. BMC Med. 2010;13(8):83.","journal-title":"BMC Med."},{"issue":"1","key":"1712_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2004.08.007","volume":"100","author":"AN Lukyanov","year":"2004","unstructured":"Lukyanov AN, et al. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. Control Release. 2004;100(1):135\u201344.","journal-title":"Control Release."},{"issue":"2","key":"1712_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ijpharm.2004.10.009","volume":"288","author":"Z Xu","year":"2005","unstructured":"Xu Z, et al. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm. 2005;288(2):361\u20138.","journal-title":"Int J Pharm"},{"issue":"4","key":"1712_CR13","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.phrs.2011.06.015","volume":"64","author":"Z Shen","year":"2011","unstructured":"Shen Z, et al. A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy. Pharmacol Res. 2011;64(4):410\u20139.","journal-title":"Pharmacol Res"},{"issue":"6","key":"1712_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.410440603","volume":"44","author":"DC Chugani","year":"1998","unstructured":"Chugani DC, et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-l-tryptophan positron emission tomography. Ann Neurol. 1998;44(6):858\u201366.","journal-title":"Ann Neurol"},{"issue":"8","key":"1712_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/j.1528-1167.2008.01615.x","volume":"49","author":"Massoud Akhtari","year":"2008","unstructured":"Akhtari Massoud, Bragin Anatol, Cohen Mark, et al. Functionalized magnetona noparticles for MRI diagnosis and localization in epilepsy. Epilepsia. 2008;49(8):1419\u201330.","journal-title":"Epilepsia."},{"issue":"5","key":"1712_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2217\/bmm.11.68","volume":"5","author":"A Kumar","year":"2011","unstructured":"Kumar A, et al. \u03b1-[11C]- methyl-l-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies. Biomarkers Med. 2011;5(5):577\u201384.","journal-title":"Biomarkers Med."},{"issue":"12","key":"1712_CR17","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1111\/epi.12412","volume":"54","author":"S Rub\u00ed","year":"2013","unstructured":"Rub\u00ed S, et al. Positron emission tomography with \u03b1-[11C] methyl-l-tryptophan in tuberous sclerosis complex-related epilepsy. Epilepsia. 2013;54(12):2143\u201350.","journal-title":"Epilepsia."},{"issue":"4","key":"1712_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1053\/j.semnuclmed.2016.01.003","volume":"46","author":"EL Erg\u00fcn","year":"2016","unstructured":"Erg\u00fcn EL, et al. SPECT-PET in epilepsy and clinical approach in evaluation. Semin Nucl Med. 2016;46(4):294\u2013307.","journal-title":"Semin Nucl Med"},{"issue":"5","key":"1712_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/08830738050200050701","volume":"20","author":"K Kaqawa","year":"2005","unstructured":"Kaqawa K, et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha- [11C] methyl-L-trypotophan position emission tomograpgy (PET). Child Neurol. 2005;20(5):429\u201338.","journal-title":"Child Neurol."},{"issue":"9","key":"1712_CR20","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1212\/WNL.57.9.1629","volume":"57","author":"M Fedi","year":"2001","unstructured":"Fedi M, et al. Localizing value of alpha-methyl-l-tryptophan PET in intractable epilepsy of neocortical origin. Neurology. 2001;57(9):1629\u201336.","journal-title":"Neurology."},{"key":"1712_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1052-5149(03)00090-X","volume":"4","author":"C Juhasz","year":"2003","unstructured":"Juhasz C, et al. Imaging the epileptic brain with positron emission tomography. Neuroimag Clin N Am. 2003;4:705\u201316.","journal-title":"Neuroimag Clin N Am"},{"issue":"5","key":"1712_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1212\/01.WNL.0000052682.99812.F5","volume":"60","author":"J Natsume","year":"2003","unstructured":"Natsume J, et al. Alpha-[11C] methyl-l-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology. 2003;60(5):756\u201361.","journal-title":"Neurology."},{"issue":"5","key":"1712_CR23","first-page":"429","volume":"20","author":"K Kaqawa","year":"2005","unstructured":"Kaqawa K, et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha- [11C] methyl-l-trypotophan position emission tomograpgy (PET). ChildNeurol. 2005;20(5):429\u201338.","journal-title":"ChildNeurol."},{"issue":"4","key":"1712_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s10548-012-0231-4","volume":"25","author":"M Akhtari","year":"2012","unstructured":"Akhtari M, et al. Imaging brain neuronal activity using functionalized magnetonanoparticles and MRI. Brain Topogr. 2012;25(4):374\u201388.","journal-title":"Brain Topogr"},{"key":"1712_CR25","first-page":"2412958","volume":"2016","author":"T Fu","year":"2016","unstructured":"Fu T, Kong Q, et al. Value of functionalized superparamagnetic iron oxide nanoparticles in the diagnosis and treatment of acute temporal lobe epilepsy on MRI. Neural Plast. 2016;2016:2412958.","journal-title":"Neural Plast."},{"issue":"6","key":"1712_CR26","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1038\/ncomms7031","volume":"23","author":"MR Johnson","year":"2015","unstructured":"Johnson MR, et al. Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus. Nat Commun. 2015;23(6):6031.","journal-title":"Nat Commun."},{"issue":"1","key":"1712_CR27","first-page":"43","volume":"11","author":"A Vezzani","year":"2010","unstructured":"Vezzani A, et al. ICE\/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr Opin Investig Drugs. 2010;11(1):43\u201350.","journal-title":"Curr Opin Investig Drugs"},{"issue":"2","key":"1712_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","volume":"8","author":"M Maroso","year":"2011","unstructured":"Maroso M, et al. Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics. 2011;8(2):304\u201315.","journal-title":"Neurotherapeutics."},{"issue":"3","key":"1712_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nbd.2011.05.015","volume":"44","author":"D Akin","year":"2011","unstructured":"Akin D, et al. IL-1beta is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence. Neurobiol Dis. 2011;44(3):259\u201369.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1712_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1742-2094-8-29","volume":"8","author":"JT Jarvela","year":"2011","unstructured":"Jarvela JT, et al. Temporal profiles of age-dependent changes in cytokine mRNA expression and glial cell activation after status epilepticus in postnatal rat hippocampus. J Neuroinflamm. 2011;8(8):29.","journal-title":"J Neuroinflamm"},{"issue":"2","key":"1712_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1535-7511.2007.00165.x","volume":"7","author":"A Vezzani","year":"2007","unstructured":"Vezzani A, et al. New roles for interleukin-1 beta in the mechanisms of epilepsy. Epilepsy Curr. 2007;7(2):45\u201350.","journal-title":"Epilepsy Curr."},{"issue":"Pt A","key":"1712_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","volume":"96","author":"A Vezzani","year":"2015","unstructured":"Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96(Pt A):70\u201382.","journal-title":"Neuropharmacology"},{"key":"1712_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-94-017-8914-1_14","volume":"813","author":"KS Wilcox","year":"2014","unstructured":"Wilcox KS, et al. Does brain inflammation mediate pathological outcomes in epilepsy? Adv Exp Med Biol. 2014;813:169\u201383.","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"1712_CR34","doi-asserted-by":"publisher","first-page":"e44518","DOI":"10.1371\/journal.pone.0044518","volume":"7","author":"M Pedrazzi","year":"2012","unstructured":"Pedrazzi M, et al. Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein. PLoS ONE. 2012;7(8):e44518.","journal-title":"PLoS ONE"},{"key":"1712_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.nbd.2015.07.003","volume":"82","author":"C Roseti","year":"2015","unstructured":"Roseti C, et al. GABAA currents are decreased by IL-1\u03b2 in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis. Neurobiol Dis. 2015;82:311\u201320.","journal-title":"Neurobiol Dis"},{"key":"1712_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nbd.2013.03.006","volume":"58","author":"V Iori","year":"2013","unstructured":"Iori V, et al. Receptor for advanced glycation endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis. 2013;58:102\u201314.","journal-title":"Neurobiol Dis"},{"key":"1712_CR37","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1089\/ars.2013.5349","volume":"21","author":"S Balosso","year":"2014","unstructured":"Balosso S, et al. Disulfide-containing high mobility group box-1 promotes N-methyl-d-aspartate receptor function and excitotoxicity by activating toll-like receptor 4-dependent signaling in hippocampal neurons. Antioxid Redox Signal. 2014;21:1726\u201340.","journal-title":"Antioxid Redox Signal"},{"key":"1712_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jneuroim.2015.04.003","volume":"282","author":"Z Xiao","year":"2015","unstructured":"Xiao Z, et al. Lobe epilepsy through the PI3K\/Akt\/mTOR signaling pathway in hippocampal neurons. J Neuroimmunol. 2015;282:110\u20137.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"1712_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","volume":"36","author":"R Dantzer","year":"2011","unstructured":"Dantzer R, O\u2019Connor JC, Lawson MA, et al. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011;36(3):426\u201336.","journal-title":"Psychoneuroendocrinology."},{"issue":"4","key":"1712_CR40","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/npp.2011.277","volume":"37","author":"PA Zunszain","year":"2012","unstructured":"Zunszain PA, Anacker C, Cattaneo A, et al. Interleukin-1\u03b2: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology. 2012;37(4):939.","journal-title":"Neuropsychopharmacology."},{"key":"1712_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-2094-11-41","volume":"11","author":"W Xie","year":"2014","unstructured":"Xie W, et al. Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy. J Neuroinflamm. 2014;11:41.","journal-title":"J Neuroinflamm"},{"key":"1712_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2015.09.002","volume":"308","author":"AL Col\u00edn-Gonz\u00e1lez","year":"2015","unstructured":"Col\u00edn-Gonz\u00e1lez AL, Paz-Loyola AL, Serratos I, et al. Toxic synergism between quinolinic acid and organic acids accumulating in glutaric acidemia type I and in disorders of propionate metabolism in rat brain synaptosomes: relevance for metabolic acidemias. Neuroscience. 2015;308:64\u201374.","journal-title":"Neuroscience"},{"key":"1712_CR43","doi-asserted-by":"publisher","first-page":"R1159","DOI":"10.1152\/ajpregu.00767.2006","volume":"293","author":"F Muller","year":"2007","unstructured":"Muller F, Song W, Jang Y, et al. Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1159\u201368.","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"1712_CR44","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/00001756-200103260-00049","volume":"12","author":"A Santamar\u00eda","year":"2001","unstructured":"Santamar\u00eda A, Galv\u00e1n-Arzate S, Lis\u00fd V, et al. Quinolinic acid induces oxidative stress in rat brain synaptosomes. Neuroreport. 2001;12:871\u20134.","journal-title":"Neuroreport."},{"key":"1712_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.expneurol.2010.03.009","volume":"224","author":"P Pierozan","year":"2010","unstructured":"Pierozan P, Zamoner A, Soska \u00c2, et al. Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats. Exp Neurol. 2010;224:188\u201396.","journal-title":"Exp Neurol."},{"issue":"8","key":"1712_CR46","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin GJ. Quinolinic acid, the inescapable neurotoxin. FEBS J. 2012;279(8):1356\u201365.","journal-title":"FEBS J"},{"issue":"6","key":"1712_CR47","first-page":"2217","volume":"30","author":"M Zhao","year":"2010","unstructured":"Zhao M, et al. Magnetic paclitaxel nanoparticles inhibit glioma growth and improve the survival of rats bearing glioma xenografts. Anticancer Res. 2010;30(6):2217\u201323.","journal-title":"Anticancer Res"},{"issue":"2\/3","key":"1712_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.eplepsyres.2012.10.006","volume":"103","author":"Z Michalak","year":"2013","unstructured":"Michalak Z, Sano T, Engel T, et al. Spatio-temporally restricted blood brain barrier disruption after intra-amy-gdala kainic acid-induced status epilepticus in mice. Epilepsy Res. 2013;103(2\/3):167\u201379.","journal-title":"Epilepsy Res."},{"issue":"11","key":"1712_CR49","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/j.1528-1167.2006.00817.x","volume":"47","author":"E Oby","year":"2006","unstructured":"Oby E, et al. The blood\u2013brain barrier and epilepsy. Epilepsia. 2006;47(11):1761\u201374.","journal-title":"Epilepsia."},{"issue":"28","key":"1712_CR50","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1002\/anie.200701674","volume":"47","author":"YW Jun","year":"2008","unstructured":"Jun YW, et al. Chemical design of nanoparticle probea for high-peformance magnetic resonance imaging. Angew Chem Int Ed. 2008;47(28):5122\u201335.","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"1712_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/jcbfm.2009.192","volume":"30","author":"JS Weinstein","year":"2010","unstructured":"Weinstein JS, et al. Superparamagnetic iron oxide nanop articles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab. 2010;30(1):15\u201335.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"1712_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/CBM-2009-0578","volume":"5","author":"T Islam","year":"2009","unstructured":"Islam T, Harisinghani MG. Overview of nanoparticle use in cancer imaging. Cancer Biomark. 2009;5(2):61\u20137.","journal-title":"Cancer Biomark."},{"issue":"10","key":"1712_CR53","first-page":"2595","volume":"1","author":"C Ndong","year":"2015","unstructured":"Ndong C, Toraya-Brown S, Kekalo K, et al. Antibody-mediated targeting of iron oxide nanoparticles to the folate receptor alpha increases tumor cell association in vitro and in vivo. Int J Nanomed. 2015;1(10):2595\u2013617.","journal-title":"Int J Nanomed."},{"issue":"5","key":"1712_CR54","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2217\/bmm.11.73","volume":"5","author":"DC Chugani","year":"2011","unstructured":"Chugani DC, et al. \u03b1-methyl-l-tryptophan: mechanisms for tracer localization of epileptogenic brain regions. Biomark Med. 2011;5(5):567\u201375.","journal-title":"Biomark Med."},{"key":"1712_CR55","first-page":"1757","volume":"24","author":"DC Chugani","year":"1998","unstructured":"Chugani DC, Heyes MP, Kuhn DM, Chugani HT. Evidence that \u03b1[11C] methyl-l-tryptophan PET traces tryptophan metabolism via the kynurenine pathway in tuberous sclerosis complex. Soc Neurosci Abstracts. 1998;24:1757.","journal-title":"Soc Neurosci Abstracts."},{"issue":"1","key":"1712_CR56","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00004647-200001000-00002","volume":"20","author":"DC Chuqani","year":"2000","unstructured":"Chuqani DC, et al. Alpha[C-ll]methyl-l-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. Cereb Blood Flow Metab. 2000;20(1):2\u20139.","journal-title":"Cereb Blood Flow Metab."},{"key":"1712_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","volume":"244","author":"A Vezzani","year":"2013","unstructured":"Vezzani A, et al. Epilepsy and brain inflammation. Exp Neurol. 2013;244:11\u201321.","journal-title":"Exp Neurol"},{"key":"1712_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s12035-013-8522-7","volume":"49","author":"N Gan","year":"2014","unstructured":"Gan N, et al. Myoloid-related protein 8, an endogenous ligand of Toll-like receptor 4, is 2 involved in epileptogenesis of mesial temporal lobe epilepsy via activation of the nuclear factor-kappaB pathway in astrocytes. Mol Neurobiol. 2014;49:337\u201351.","journal-title":"Mol Neurobiol"},{"issue":"Pt 5","key":"1712_CR59","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/awv066","volume":"138","author":"MA Michell-Robinson","year":"2015","unstructured":"Michell-Robinson MA, et al. Roles of microglia in brain development, tissue maintenance and repair. Brain. 2015;138(Pt 5):1138\u201359.","journal-title":"Brain"},{"issue":"12","key":"1712_CR60","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nm.1878","volume":"14","author":"PF Fabene","year":"2008","unstructured":"Fabene PF, et al. A role for leuukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med. 2008;14(12):1377\u201383.","journal-title":"Nat Med"},{"issue":"2","key":"1712_CR61","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nbd.2011.06.011","volume":"44","author":"F Deprez","year":"2011","unstructured":"Deprez F, et al. Adoptive transfer of T lymphocytes in immunodeficient mice influences epileptogenesis and neurodegeneration in a model of temporal lobe epilepsy. Neurobiol Dis. 2011;44(2):174\u201384.","journal-title":"Neurobiol Dis"},{"issue":"20","key":"1712_CR62","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1523\/JNEUROSCI.17-20-07817.1997","volume":"17","author":"L Pasti","year":"1997","unstructured":"Pasti L, et al. Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ. J Neurosci. 1997;17(20):7817\u201330.","journal-title":"J Neurosci"},{"issue":"5","key":"1712_CR63","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.neuron.2004.08.011","volume":"43","author":"T Fellin","year":"2004","unstructured":"Fellin T, et al. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron. 2004;43(5):729\u201343.","journal-title":"Neuron"},{"issue":"8","key":"1712_CR64","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/j.1528-1167.2009.02472.x","volume":"51","author":"G Losi","year":"2010","unstructured":"Losi G, et al. A new experimental model of focal seizures in the entorhinal cortex. Epilepsia. 2010;51(8):1493\u2013502.","journal-title":"Epilepsia."},{"issue":"1\u20132","key":"1712_CR65","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.brainresrev.2009.10.004","volume":"63","author":"G Seifert","year":"2010","unstructured":"Seifert G, et al. Astrocyte dysfunction in epilepsy. Brain Res Rev. 2010;63(1\u20132):212\u201321.","journal-title":"Brain Res Rev"},{"issue":"5154","key":"1712_CR66","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1126\/science.8134839","volume":"263","author":"M Nedergaard","year":"1994","unstructured":"Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science. 1994;263(5154):1768\u201371.","journal-title":"Science"},{"issue":"8","key":"1712_CR67","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nri1664","volume":"5","author":"SM Allan","year":"2005","unstructured":"Allan SM, et al. Interleukin-1 and neuronal injury. Nat Rev Immunol. 2005;5(8):629\u201340.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1712_CR68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57\u201369.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1712_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2014.06.008","volume":"158","author":"MW Salter","year":"2014","unstructured":"Salter MW, Beggs S. Sublime microglia: expanding roles for the guardians of the CNS. Cell. 2014;158(1):15\u201324.","journal-title":"Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1712-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1712-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1712-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T19:29:18Z","timestamp":1575401358000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1712-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1712"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1712-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"337"}}